Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Cirrhosis

  Free Subscription


Articles published in Intern Med

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    February 2019
  1. NAGAYAMA I, Masuda T, Nakagawa S, Murakami T, et al
    Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease.
    Intern Med. 2019 Feb 1. doi: 10.2169/internalmedicine.2174.
    PubMed     Text format     Abstract available


    January 2019
  2. SATO T, Endo K, Kakisaka K, Suzuki Y, et al
    Decreased Mean Kurtosis in the Putamen is a Diagnostic Feature of Minimal Hepatic Encephalopathy in Patients with Cirrhosis.
    Intern Med. 2019 Jan 10. doi: 10.2169/internalmedicine.2116.
    PubMed     Text format     Abstract available


    December 2018
  3. YANG J, Lun Y, Shuai X, Liu T, et al
    Late-onset Hemochromatosis: Co-inheritance of beta-thalassemia and Hereditary Hemochromatosis in a Chinese Family: A Case Report and Epidemiological Analysis of Diverse Populations.
    Intern Med. 2018;57:3433-3438.
    PubMed     Text format     Abstract available


    November 2018
  4. YAMAUCHI R, Takata K, Shinagawa Y, Tanaka T, et al
    Hepatocellular Carcinoma Arising in a Non-cirrhotic Liver with Secondary Hemochromatosis.
    Intern Med. 2018 Nov 19. doi: 10.2169/internalmedicine.0973.
    PubMed     Text format     Abstract available


  5. SEIKE T, Komura T, Shimizu Y, Omura H, et al
    A Young Man with Non-alcoholic Steatohepatitis and Serum Anti-mitochondrial Antibody Positivity.
    Intern Med. 2018;57:3093-3097.
    PubMed     Text format     Abstract available


    October 2018
  6. ICHIKAWA T, Machida N, Kaneko H, Oi I, et al
    C-Reactive Protein can Predict Patients with Cirrhosis at a High Risk of Early Mortality after Acute Esophageal Variceal Bleeding.
    Intern Med. 2018 Oct 17. doi: 10.2169/internalmedicine.1447.
    PubMed     Text format     Abstract available


  7. MIYASAKA A, Yoshida Y, Yoshida T, Murakami A, et al
    The Real-world Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir for Hepatitis C Genotype 1.
    Intern Med. 2018;57:2807-2812.
    PubMed     Text format     Abstract available


    July 2018
  8. AKASHI M, Tajiri K, Wada A, Tsuneyama K, et al
    A Patient with Non-alcoholic Steatohepatitis Complicated by Multiple Myeloma.
    Intern Med. 2018;57:2013-2018.
    PubMed     Text format     Abstract available


  9. MATSUOKA S, Yamana Y, Ishii T, Kumagawa M, et al
    Portal-systemic Encephalopathy due to Complicated Spleno-renal Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration Using a Double Coaxial Balloon Catheter System and Shape-memory Coils.
    Intern Med. 2018;57:1861-1866.
    PubMed     Text format     Abstract available


    June 2018
  10. KAWANO A, Shigematsu H, Miki K, Ichiki Y, et al
    Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study.
    Intern Med. 2018;57:1533-1542.
    PubMed     Text format     Abstract available


    May 2018
  11. KAMIO T, Hiraoka E, Obunai K, Watanabe H, et al
    Constrictive Pericarditis as a Long-term Undetermined Etiology of Ascites and Edema.
    Intern Med. 2018;57:1487-1491.
    PubMed     Text format     Abstract available


    April 2018
  12. KASUGA K, Sako M, Kasai S, Yoshimoto H, et al
    A Case of Rat Bite Fever Caused by Streptobacillus moniliformis in a Cirrhotic Patient Initially Presenting with Various Systemic Features Resembling Henoch-Schonlein Purpura.
    Intern Med. 2018 Apr 27. doi: 10.2169/internalmedicine.9856.
    PubMed     Text format     Abstract available


  13. KONISHI H, Fukuzawa K, Mori S, Satomi-Kobayashi S, et al
    Anti-mitochondrial M2 Antibodies and Myopathy: Author's Reply.
    Intern Med. 2018;57:1189.
    PubMed     Text format    


    March 2018
  14. HAYASHI M, Abe K, Fujita M, Okai K, et al
    Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
    Intern Med. 2018 Mar 30. doi: 10.2169/internalmedicine.0629.
    PubMed     Text format     Abstract available


  15. KITAGAWA S, Oku D, Okamura K
    Spontaneous Mesenteric-gonadal Shunt in a Patient without Cirrhosis.
    Intern Med. 2018 Mar 9. doi: 10.2169/internalmedicine.0599.
    PubMed     Text format    


    December 2017
  16. IKARASHI Y, Kodama K, Taniai M, Hashimoto E, et al
    The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus.
    Intern Med. 2017 Dec 21. doi: 10.2169/internalmedicine.9853.
    PubMed     Text format     Abstract available


  17. UOJIMA H, Murakami S, Nakatani S, Hidaka H, et al
    Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis.
    Intern Med. 2017 Dec 8. doi: 10.2169/internalmedicine.9671.
    PubMed     Text format     Abstract available


  18. NAKATANI R, Murata T, Usui T, Moriyoshi K, et al
    Importance of the Average Glucose Level and Estimated Glycated Hemoglobin in a Diabetic Patient with Hereditary Hemolytic Anemia and Liver Cirrhosis.
    Intern Med. 2017 Dec 8. doi: 10.2169/internalmedicine.9135.
    PubMed     Text format     Abstract available


    November 2017
  19. KOMURA T, Ohta H, Seike T, Shimizu Y, et al
    The Efficacy of Corticosteroid Therapy in a Patient with Nonalcoholic Steatohepatitis Overlapping Autoimmune Hepatitis: A Case Report.
    Intern Med. 2017 Nov 20. doi: 10.2169/internalmedicine.8887.
    PubMed     Text format     Abstract available


    September 2017
  20. KOGISO T, Kobayashi M, Yamamoto K, Ikarashi Y, et al
    The Outcome of Cirrhotic Patients with Ascites is Improved by the Normalization of the Serum Sodium Level by Tolvaptan.
    Intern Med. 2017 Sep 25. doi: 10.2169/internalmedicine.9033.
    PubMed     Text format     Abstract available


    August 2017
  21. HARADA M, Yoneda A, Haruyama S, Yabuki K, et al
    Bullous Pemphigoid Associated with the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in a Patient with Liver Cirrhosis Complicated with Rapidly Progressive Hepatocellular Carcinoma.
    Intern Med. 2017 Aug 21. doi: 10.2169/internalmedicine.8703.
    PubMed     Text format     Abstract available


    January 2017
  22. CHISHIMA S, Kogiso T, Matsushita N, Hashimoto E, et al
    The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
    Intern Med. 2017;56:473-480.
    PubMed     Text format     Abstract available


    January 2016
  23. IWAMOTO T, Maeda M, Hisanaga T, Saeki I, et al
    Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis.
    Intern Med. 2016;55:2911-2916.
    PubMed     Text format     Abstract available


  24. TAKUMA Y, Fukada Y, Iwadou S, Miyatake H, et al
    Surgical Resection for Hepatocellular Carcinoma with Cardiac Cirrhosis after the Fontan Procedure.
    Intern Med. 2016;55:3265-3272.
    PubMed     Text format     Abstract available


  25. HAGIWARA S, Nishida N, Chishina H, Ida H, et al
    Cases with Refractory Ascites and a Delayed Response to Tolvaptan.
    Intern Med. 2016;55:3273-3277.
    PubMed     Text format     Abstract available


  26. KOGISO T, Hashimoto E, Ito T, Hara T, et al
    Successful Treatment of Ascites using a Denver(R) Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome.
    Intern Med. 2016;55:2957-2963.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: